U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07164807) titled 'Efficacy of Methylene Blue Plus Ropivacaine for Post-Hemorrhoidectomy Pain.' on Aug. 29.
Brief Summary: Revised Translation (Academic English):
As one of the most prevalent anorectal disorders, mixed hemorrhoids continue to rely on the Milligan-Morgan hemorrhoidectomy as the gold-standard surgical approach. While this technique demonstrates well-established efficacy, managing acute postoperative pain-particularly during the critical 24-72-hour peak pain window-remains a persistent clinical challenge. Recent advancements in multimodal analgesia have highlighted the potential of local nerve blockers, with methylene blue (MB) gaining...